Additional analyses of the two trials presented at 2023 ESC Congress
Robust reductions in cardiac events seen in high-risk patients without prior events
Findings bolster the oral drug as an option for primary and secondary prevention
Updated guidance on identification and strategies for management
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Intermittent statin dosing & bempedoic acid refresh the mix of options
Reduces muscle pain caused by cholesterol-lowering drugs